San Diego-based Predictive Science, Inc. this week released their first forecast for the 2019-2020 influenza season, which typically runs from November through March.
Researchers at the San Diego Supercomputer Center at UC San Diego have launched an open-source software called SeedMeLab, which provides a host of features for researchers across all disciplines to manage and disseminate their data.
Researchers at SDSC and UC San Diego School of Medicine have received two National Science Foundation (NSF) planning grants worth a combined $2 million to invest in research collaborations between academia, industry, government, and communities.
Three University of California San Diego researchers have received prestigious awards through the National Institutes of Health (NIH) High-Risk, High-Reward Research Program, including the Pioneer Award, the program’s top honor.
Scientists have gained a new understanding of how ultra-resilient tardigrades, or “water bears,” are protected in extreme conditions. The researchers discovered that a protein named Dsup binds and forms a protective cloud against extreme survival threats such as radiation damage.
Studying natural defenses in maize, a staple of diets around the world, UC San Diego biologists describe how they combined an array of scientific approaches to clearly define six genes that encode enzymes responsible for the production of key maize antibiotics known to control disease resistance.
Bioengineers and biologists at the University of California San Diego have developed a method to significantly extend the life of gene circuits used to instruct microbes to do things such as produce and deliver drugs, break down chemicals and serve as environmental sensors.
Researchers at SDSC, LANL, and UNC Chapel Hill have developed a machine learning approach called transfer learning that lets them model novel materials by learning from data collected about millions of other compounds.
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.